Molecular genetic analysis of non-astrocytic gliomas

Affiliations

Comment

S T Al-Sarraj. Histopathology. 1999 Apr.

. 1999 Apr;34(4):370-1.

doi: 10.1046/j.1365-2559.1999.00655.x.

No abstract available

Comment on

Molecular genetic analysis of non-astrocytic gliomas.
Tong CY, Ng HK, Pang JC, Hui AB, Ko HC, Lee JC. Tong CY, et al. Histopathology. 1999 Apr;34(4):331-41. doi: 10.1046/j.1365-2559.1999.00603.x. Histopathology. 1999. PMID: 10231401

Molecular genetic analysis of non-astrocytic gliomas.
Tong CY, Ng HK, Pang JC, Hui AB, Ko HC, Lee JC. Tong CY, et al. Histopathology. 1999 Apr;34(4):331-41. doi: 10.1046/j.1365-2559.1999.00603.x. Histopathology. 1999. PMID: 10231401
Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.
Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP. Reifenberger G, et al. Cancer Res. 1993 Jun 15;53(12):2736-9. Cancer Res. 1993. PMID: 8504413
The p53/Mdm2/p14ARF cell cycle control pathway genes may be inactivated by genetic and epigenetic mechanisms in gliomas.
Bello MJ, Rey JA. Bello MJ, et al. Cancer Genet Cytogenet. 2006 Jan 15;164(2):172-3. doi: 10.1016/j.cancergencyto.2005.07.002. Cancer Genet Cytogenet. 2006. PMID: 16434325 No abstract available.
Correlation of molecular genetic analysis of p53, MDM2, p16, PTEN, and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma.
Ushio Y, Tada K, Shiraishi S, Kamiryo T, Shinojima N, Kochi M, Saya H. Ushio Y, et al. Front Biosci. 2003 May 1;8:e281-8. doi: 10.2741/865. Front Biosci. 2003. PMID: 12700122 Review.
[Mdm2, p53 and the cell cycle: when well enough is best left alone].
Maréchal V. Maréchal V. Pathol Biol (Paris). 1997 Dec;45(10):824-32. Pathol Biol (Paris). 1997. PMID: 9769946 Review. French.